EKAYANTI, Ni Kd Rintan Listiani et al.
 COST ANALYSIS OF PATIENTS WITH SQUAMOUS CELL CERVICAL CANCER STAGE IIB-IIIB WITH PACLITAXEL CISPLATIN CHEMOTHERAPY FROM THE SOCIETAL PERSPECTIVE.
<strong>Journal Pharmaceutical Science and Application</strong>, [S.l.], v. 5, n. 1, p. 34-44, june 2023.
ISSN 2301-7708.
Available at: &lt;<a href="https://ojs.unud.ac.id/index.php/jpsa/article/view/99999" target="_new">https://ojs.unud.ac.id/index.php/jpsa/article/view/99999</a>&gt;. Date accessed: 11 feb. 2025.
doi: <a href="https://doi.org/10.24843/JPSA.2023.v05.i01.p05">https://doi.org/10.24843/JPSA.2023.v05.i01.p05</a>.